| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |